Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124715702 | 12471570 | 2 | F | 20150213 | 20160721 | 20160616 | 20160726 | EXP | JP-ASTELLAS-2016JP009300 | ASTELLAS | 46.26 | YR | M | Y | 0.00000 | 20160726 | MD | JP | JP |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124715702 | 12471570 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 37.5 | MG | 204096 | 1.5 | MG | MODIFIED-RELEASE CAPSULE, HARD | QD | |||||
| 124715702 | 12471570 | 2 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | U | 0 | 125 | MG | FORMULATION UNKNOWN | QD | ||||||
| 124715702 | 12471570 | 3 | SS | NEORAL | CYCLOSPORINE | 1 | Unknown | 0 | 75 | MG | FORMULATION UNKNOWN | QD | |||||||
| 124715702 | 12471570 | 4 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | Oral | U | 0 | 4 | MG | PER ORAL NOS | QD | ||||||
| 124715702 | 12471570 | 5 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 1250 | MG | PER ORAL NOS | QD | ||||||
| 124715702 | 12471570 | 6 | C | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | Oral | U | 0 | 500 | MG | PER ORAL NOS | QD | ||||||
| 124715702 | 12471570 | 7 | C | EVEROLIMUS | EVEROLIMUS | 1 | Oral | 0.5 MG, ONCE DAILY | U | 0 | .5 | MG | PER ORAL NOS | QD | |||||
| 124715702 | 12471570 | 8 | C | CALBLOCK | AZELNIDIPINE | 1 | Unknown | U | 0 | 16 | MG | FORMULATION UNKNOWN | QD | ||||||
| 124715702 | 12471570 | 9 | C | ARTIST | CARVEDILOL | 1 | Unknown | U | 0 | 10 | MG | FORMULATION UNKNOWN | QD | ||||||
| 124715702 | 12471570 | 10 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | Unknown | U | 0 | 40 | MG | FORMULATION UNKNOWN | QD | ||||||
| 124715702 | 12471570 | 11 | C | CARDENALIN | DOXAZOSIN MESYLATE | 1 | Unknown | U | 0 | 2 | MG | FORMULATION UNKNOWN | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124715702 | 12471570 | 1 | Prophylaxis against transplant rejection |
| 124715702 | 12471570 | 2 | Prophylaxis against transplant rejection |
| 124715702 | 12471570 | 4 | Prophylaxis against transplant rejection |
| 124715702 | 12471570 | 5 | Prophylaxis against transplant rejection |
| 124715702 | 12471570 | 7 | Prophylaxis against transplant rejection |
| 124715702 | 12471570 | 8 | Hypertension |
| 124715702 | 12471570 | 9 | Hypertension |
| 124715702 | 12471570 | 10 | Hypertension |
| 124715702 | 12471570 | 11 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124715702 | 12471570 | HO |
| 124715702 | 12471570 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124715702 | 12471570 | Transplant rejection |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124715702 | 12471570 | 1 | 20150120 | 20150330 | 0 | |
| 124715702 | 12471570 | 3 | 20150119 | 0 |